Clinical Trials Browser

Phase 1 × OTHER × donafenib × Clear all

NCT04418401 2026-02-17

CISLD-8

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT04059874 2019-08-16

Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung